Why Choose The Microbiome Drug Development Summit?
The Microbiome Drug Development Summit continues to be the industry leading forum that focuses exclusively on the development and commercialization of microbiome-based therapeutics; with case-studies from target discovery all the way through to clinical trial development, manufacturing and beyond.
As microbiome-based therapeutics come in many forms, drug developers battle with critical challenges in product development such as pre-clinical evaluation, clinical trial design, CMC considerations and regulatory uncertainty. With that in mind, the 3rd Annual Microbiome Drug Development Summit will once again unite KOL’s, senior drug developers, microbiome-technology experts and breakthrough researchers to translate the human microbiome into simply effective medicines. View the event guide to find out more.
Microbiome Drug Development Summit, Boston, June 2017: Your Highlights